SEARCH

SEARCH BY CITATION

References

  • 1
    Norén K, Meironyté D. Certain organochlorine and organobromine contaminants in Swedish human milk in perspective of past 20-30 years. Chemosphere 2000; 40: 1111-1123.
  • 2
    Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002; 8: 185-192.
  • 3
    Grün F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 2007; 8: 161-171.
  • 4
    Lee DH, Lee IK, Porta M, Steffes M, Jacobs DR Jr. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 2007; 50: 1841-1851.
  • 5
    Neel BA, Sargis RM. The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes 2011; 60: 1838-1848.
  • 6
    Newbold RR. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens) 2010; 9: 206-217.
  • 7
    Finucane MM, Stevens GA, Cowan MJ et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011; 377: 557-567.
  • 8
    Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62-66.
  • 9
    Fact sheet No 311: Obesity and overweight <http://www.who.int/mediacentre/factsheets/fs311/en/index.html> ( 2011). Accessed 30 November 2011.
  • 10
    Dhooge W, Den Hond E, Koppen G et al. Internal exposure to pollutants and body size in Flemish adolescents and adults: associations and dose-response relationships. Environ Int 2010; 36: 330-337.
  • 11
    Dirinck E, Jorens PG, Covaci A et al. Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring) 2011; 19: 709-714.
  • 12
    Elobeid MA, Padilla MA, Brock DW, Ruden DM, Allison DB. Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data. Int J Environ Res Public Health 2010; 7: 2988-3005.
  • 13
    Lee DH, Lind L, Jacobs DR Jr et al. Associations of persistent organic pollutants with abdominal obesity in the elderly: The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Environ Int 2012; 40: 170-178.
  • 14
    Lee DH, Steffes MW, Sjödin A et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS ONE 2011; 6: e15977.
  • 15
    Rönn M, Lind L, van Bavel B et al. Circulating levels of persistent organic pollutants associate in divergent ways to fat mass measured by DXA in humans. Chemosphere 2011; 85: 335-343.
  • 16
    Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease in men. Lancet 1987; 1: 821-824.
  • 17
    Ohlson LO, Larsson B, Svärdsudd K et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34: 1055-1058.
  • 18
    Salihovic S, Mattioli L, Lindström G et al. A rapid method for screening of the Stockholm Convention POPs in small amounts of human plasma using SPE and HRGC/HRMS. Chemosphere 2012; 86: 747-753.
  • 19
    Kullberg J, von Below C, Lönn L et al. Practical approach for estimation of subcutaneous and visceral adipose tissue. Clin Physiol Funct Imaging 2007; 27: 148-153.
  • 20
    Daston GP, Cook JC, Kavlock RJ. Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 2003; 74: 245-252.
  • 21
    Welshons WV, Thayer KA, Judy BM et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 2003; 111: 994-1006.
  • 22
    Medlock KL, Lyttle CR, Kelepouris N, Newman ED, Sheehan DM. Estradiol down-regulation of the rat uterine estrogen receptor. Proc Soc Exp Biol Med 1991; 196: 293-300.
  • 23
    Milbrath MO, Wenger Y, Chang CW et al. Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding. Environ Health Perspect 2009; 117: 417-425.
  • 24
    Wolff MS, Anderson HA, Britton JA, Rothman N. Pharmacokinetic variability and modern epidemiology-the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort. Cancer Epidemiol Biomarkers Prev 2007; 16: 1925-1930.
  • 25
    Yu GW, Laseter J, Mylander C. Persistent organic pollutants in serum and several different fat compartments in humans. J Environ Public Health 2011; 2011: 417980.
  • 26
    Lee DH, Lind PM, Jacobs DR Jr et al. Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study. Diabetes Care 2011; 34: 1778-1784.